ConductScience.org, home

Paper30008323

EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.

Zingg D and 17 others. Cancer Cell, 2018. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation. Papers, record 30008323. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30008323

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.
PubMed
Journal
Cancer Cell
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
3.39
iCite
Revised in PubMed
2022-04-09
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zingg DDaniel
2Debbache JJulien
3Peña-Hernández RRodrigo
4Antunes ATAna T
5Schaefer SMSimon M
6Cheng PFPhil F
7Zimmerli DDario
8Haeusel JJessica
9Calçada RRRaquel R
10Tuncer EEylul
11Zhang YYudong
12Bossart RRaphaël
13Wong KKKwok-Kin
14Basler KKonrad
15Dummer RReinhard
16Santoro RRaffaella
17Levesque MPMitchell P
18Sommer LLukas

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell MovementMajor topic
Cell ProliferationMajor topic
CiliaMajor topic
Enhancer of Zeste Homolog 2 ProteinMajor topic
MelanocytesMajor topic
MelanomaMajor topic
Skin NeoplasmsMajor topic
Animals
Cell Line, Tumor
Cell Transformation, Neoplastic
Female
GTP Phosphohydrolases
Gene Expression Regulation, Neoplastic
HEK293 Cells
Humans
Lymphatic Metastasis
Male
Membrane Proteins
Mice, Nude
Mice, Transgenic
Proto-Oncogene Proteins B-raf
Wnt Signaling Pathway
beta Catenin

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in29990499EZH2 Inactivates Primary Cilia to Activate Wnt and Drive Melanoma.https://conductscience.org/library/papers/29990499

Source PubMed

Download CSV of comments and corrections

Cited by90

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
42690564Primary cilia connect epithelial mesenchymal plasticity with anoikis resistance and cancer stemness.Discov Oncol2026https://conductscience.org/library/papers/42690564PubMed
42374968Primary cilium disassembly - from mechanisms to roles in physiology and disease.J Cell Sci2026https://conductscience.org/library/papers/42374968PubMed
42220432EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives.Oncol Res2026https://conductscience.org/library/papers/42220432PubMed
42021201A novel mutation of IFT140 in a preschool child with Mainzer-Saldino syndrome accompanied by rare tumor blastic plasmacytoid dendritic cell neoplasm: a case report.BMC Pediatr2026https://conductscience.org/library/papers/42021201PubMed
41799498Combinational Inhibition of the eIF4F Complex, AKT1, and EZH2 Enhances Anticancer Effects in BRAFV600E Mutant A375 Melanoma Cells.Oncol Res2026https://conductscience.org/library/papers/41799498PubMed
41751164Use of Small-Molecule Inhibitors of CILK1 and AURKA as Cilia-Promoting Drugs to Decelerate Medulloblastoma Cell Replication.Biomedicines2026https://conductscience.org/library/papers/41751164PubMed
41294104Primary cilia in cancer: structures, functions, mechanisms, and therapeutic implications.Cancer Biol Med2025https://conductscience.org/library/papers/41294104PubMed
41063628A novel murine model for sporadic, malignant peripheral nerve sheath tumors, driven by BrafV600E and Pten loss.Dis Model Mech2025https://conductscience.org/library/papers/41063628PubMed
40888126Taking Down the Primary Cilium: Pathways for Disassembly in Differentiating Cells.Bioessays2025https://conductscience.org/library/papers/40888126PubMed
40850308A methyl-to-acetyl switch in H3K27 drives metabolic reprogramming and resistance to BRAFV600E inhibition in melanoma.Neoplasia2025https://conductscience.org/library/papers/40850308PubMed
40017656Alteration of primary cilia and intraflagellar transport 20 (IFT20) expression in oral squamous cell carcinoma (OSCC) cell lines.PeerJ2025https://conductscience.org/library/papers/40017656PubMed
39984702Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat.NPJ Precis Oncol2025https://conductscience.org/library/papers/39984702PubMed
39705308Permanent cilia loss during cerebellar granule cell neurogenesis involves withdrawal of cilia maintenance and centriole capping.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/39705308PubMed
39676858Immunomodulatory potential of primary cilia in the skin.Front Immunol2024https://conductscience.org/library/papers/39676858PubMed
39621784Melanocortin 1 receptor mediates melanin production by interacting with the BBSome in primary cilia.PLoS Biol2024https://conductscience.org/library/papers/39621784PubMed
39389955Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC.Cell Death Dis2024https://conductscience.org/library/papers/39389955PubMed
39234399Primary cilia-associated signalling in squamous cell carcinoma of head and neck region.Front Oncol2024https://conductscience.org/library/papers/39234399PubMed
39121480Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers.Cancer Discov2024https://conductscience.org/library/papers/39121480PubMed
39113711SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation.Int J Biol Sci2024https://conductscience.org/library/papers/39113711PubMed
38902533Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation.Br J Cancer2024https://conductscience.org/library/papers/38902533PubMed

See all 90 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
EZH22146PubTator's text mininghttps://conductscience.org/library/genes/2146NCBI Gene
NRAS4893PubTator's text mininghttps://conductscience.org/library/genes/4893NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30008323

GET https://conductscience.org/api/papers/v1/30008323/cited_by?page=2